Elevated Glucose and Interleukin-1β Differentially Affect Retinal Microglial Cell Proliferation.

Area of Science:

• Ophthalmology
• Neuroscience
• Immunology

Background:

• Diabetic retinopathy (DR) is a neurovascular complication of diabetes, with hyperglycemia as a primary risk factor.
• DR exhibits chronic inflammatory characteristics, including elevated retinal cytokines like interleukin-1 beta (IL-1β).
• The precise impact of high glucose and IL-1β on distinct retinal cell types requires further elucidation.

Purpose of the Study:

• To investigate the effects of high glucose and IL-1β on retinal neural cell cultures.
• To clarify the roles of IL-1β and its receptor (IL-1RI) in different retinal cell types under diabetic conditions.
• To explore potential therapeutic strategies targeting IL-1β in diabetic retinopathy.

Main Methods:

• Utilized retinal neural cell cultures exposed to high glucose conditions.
• Quantified mRNA and protein levels of IL-1β.
• Assessed microglial and macroglial cell proliferation and morphology.
• Analyzed ED-1 expression as a marker of microglia activation.

Main Results:

• High glucose upregulated both mRNA and protein levels of IL-1β in retinal neural cell cultures.
• High glucose reduced microglial and macroglial cell proliferation, while IL-1β enhanced it.
• Under high glucose, microglia exhibited reduced numbers but a less ramified, more activated morphology (increased ED-1 levels).

Conclusions:

• IL-1β plays a significant role in diabetic retinopathy by influencing microglial and macroglial cells, contributing to neural damage.
• IL-1β is crucial for retinal microglia activation and proliferation in diabetes.
• Inhibiting IL-1β-mediated inflammatory pathways presents a promising therapeutic avenue for managing diabetic retinopathy progression.